Search for: "Myers, et al. v. United States" Results 81 - 95 of 95
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2008, 6:08 pm
Escherichia coli O157:H7 Infections in Children Associated with Raw Milk and Raw Colostrum From Cows --- California, 2006 CDC this morning published the following findings in MMWR: Five of six patients reported they had consumed brand A raw dairy products in the week before their illness onset; the sixth patient denied drinking brand A raw milk, although his family routinely purchased it. [read post]
29 May 2008, 5:55 pm
This case concerns a consolidated appeal by Sensations, Inc. et al. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
22 Jun 2007, 11:27 am
Here is the 12/17/03 opinion in D & M Healthcare, Inc., et al. v. [read post]
1 Mar 2007, 4:57 am by Ricky E. Bagolie
OCs (Estimated Relative Risk or Odds Ratio with 95% CI) Bloemenkamp et al,[8]1995 Case-Control 2.2 (0.9-5.4) Spitzer (Transnational),[9] 1996 Case-Control 1.5 (1.1-2.2) Bloemankamp et al,[13] 1999 Case-Control 1.9 (0.8-4.5) Jick et al (UK-GPRD),[14] 2000 Cohort/Case-Control 1.9 (1.3-2.8)/2.3 (1.3-3.9) Farley et al (WHO),[6] 1995 Case-Control 2.4 (1.3-4.6) Jick et al (UK-GPRD),[7] 1995 Cohort/Case-Control 1.9… [read post]